Nanomedicines for kidney diseases Journal Article

Authors: Williams, R. M.; Jaimes, E. A.; Heller, D. A.
Article Title: Nanomedicines for kidney diseases
Abstract: Nanomedicines have been the subject of great interest for the treatment, diagnosis, and research of disease; however, few specifically address kidney disorders. Nanotechnology can confer significant benefits to medicine, such as the targeted delivery of drugs to specific tissues. Nanomedicines in the clinic have increased drug solubility, reduced off-target side effects, and provided novel diagnostic tools. There is an increasing cohort of nanomaterials that may have implications for kidney disease. Here, we review nanomaterial properties that are potentially applicable to kidney research and therapy, and we highlight clinical areas of need that may benefit from kidney nanomedicines. © 2016 International Society of Nephrology
Keywords: drug development; imaging; nanoparticles; therapeutics; theranostics; diagnostics
Journal Title: Kidney International
Volume: 90
Issue: 4
ISSN: 0085-2538
Publisher: Elsevier Inc.  
Date Published: 2016-10-01
Start Page: 740
End Page: 745
Language: English
DOI: 10.1016/j.kint.2016.03.041
PROVIDER: scopus
PMCID: PMC5064150
PUBMED: 27292222
Notes: Short Survey -- Export Date: 3 April 2017 -- Source: Scopus
Citation Impact
MSK Authors
  1. Daniel Alan Heller
    73 Heller
  2. Edgar Alberto Jaimes
    47 Jaimes